Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Leukemia

Free Subscription 03.08.2026 3 Am J Hematol 4 Ann Hematol 1 Cancer Res 4 Int J Hematol 1 Leuk Lymphoma 9 Leukemia 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. OSMAN-KARDASH L, Alnajar A, Anderson AD, Madarang E, et al
   Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
   Am J Hematol. 2026 Jul 28. doi: 10.1002/ajh.70452.
   PubMed        
   
   
2. BECILLI M, Del Bufalo F, Merli P, Rosignoli C, et al
   HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naive Patients With Refractory T-Cell Acute Lymphoblastic Leukemia.
   Am J Hematol. 2026 Jul 25. doi: 10.1002/ajh.70448.
   PubMed        
   
   
3. ALSUGAIR A, Fathima S, Alhousani MM, Mariotti EG, et al
   Risk-Adjusted Comparison of Survival in Chronic Myelomonocytic Leukemia With and Without Allogeneic Stem Cell Transplant: Mayo Clinic Experience in 775 Consecutive Patients.
   Am J Hematol. 2026 Jul 24. doi: 10.1002/ajh.70453.
   PubMed         Abstract available
   
   

   
   Ann Hematol

4. MUELLER S, Pan CC, Bosak J, Hofmann J, et al
   Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.
   Ann Hematol. 2026;105:351.
   PubMed         Abstract available
   
   
5. CHEN Y, XinhongYang, Zhang Z, Yang X, et al
   AML with t(16;21)(p11.2;q22)/FUS::ERG rearrangement presenting with hemophagocytes and multinucleated cells: a case report and literature review.
   Ann Hematol. 2026;105:352.
   PubMed         Abstract available
   
   
6. ZHENG X, Luo Y, Zhang R, Liu X, et al
   CD33 expression combined with D15-MRD positivity identifies poor prognosis in children with ETV6::RUNX1-positive ALL.
   Ann Hematol. 2026;105:347.
   PubMed         Abstract available
   
   
7. DE DOMENICO R, Magliano G, Morello E, Zanon S, et al
   Calcineurin inhibitor-induced pain syndrome: an uncommon side effect of immunosuppressive therapy after allogeneic hematopoietic stem cell transplant. a case report and review of the literature.
   Ann Hematol. 2026;105:345.
   PubMed         Abstract available
   
   

   
   Cancer Res

8. XU W, Ma X, Sun X, Song G, et al
   ETV6 Rearrangement Suppresses CDKN1B Transcription by Disrupting an Intragenic Super-Enhancer in Acute Lymphoblastic Leukemia.
   Cancer Res. 2026 Jul 29. doi: 10.1158/0008-5472.CAN-25-3743.
   PubMed         Abstract available
   
   

   
   Int J Hematol

9. KASHIMURA M, Fujioka Y, Guo YM, Takahashi T, et al
   Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.
   Int J Hematol. 2026;124:295-301.
   PubMed         Abstract available
   
   
10. IMAHASHI N, Konuma T, Kobayashi S, Watanabe M, et al
    Are matched-related donors always the best choice? A retrospective study exploring the potential of umbilical cord blood.
    Int J Hematol. 2026;124:262-269.
    PubMed         Abstract available
    
    
11. FUJII F, Onozawa M, Yoshida S, Miyashita N, et al
    Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.
    Int J Hematol. 2026;124:167-176.
    PubMed         Abstract available
    
    
12. HIRAO T, Yamamoto H, Kuno M, Watanabe O, et al
    Cord blood versus matched related donor transplantation in AML not in remission: role of pre-engraftment immune reactions.
    Int J Hematol. 2026;124:270-282.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

13. ONAKA T, Imada K
    Clinical considerations associated with CPX-351 therapy for high-risk acute myeloid leukemia.
    Leuk Lymphoma. 2026 Jul 25:1-4. doi: 10.1080/10428194.2026.2704267.
    PubMed        
    
    

    
    Leukemia

14. INABA H, Varotto E, Zhou Y, Choi JK, et al
    Traumatic lumbar puncture at diagnosis in children and adolescents with acute lymphoblastic leukemia.
    Leukemia. 2026 Jul 31. doi: 10.1038/s41375-026-03082.
    PubMed        
    
    
15. LIAO C, Wen J, Ma X, Wang N, et al
    Targeting ACSF2 overcomes Ara-C resistance in acute myeloid leukemia via the cholesterol metabolism-ERK signaling axis.
    Leukemia. 2026 Jul 31. doi: 10.1038/s41375-026-03053.
    PubMed         Abstract available
    
    
16. LEHRNBECHER T, Cesaro S, Alten J, Attarbaschi A, et al
    Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009.
    Leukemia. 2026 Jul 29. doi: 10.1038/s41375-026-03084.
    PubMed        
    
    
17. SHEN L, Fan J, Wang N, Wang Z, et al
    Adaptor-mediated rewiring of FLT3 signaling engages p38 MAPK to sustain gilteritinib resistance in acute myeloid leukemia.
    Leukemia. 2026 Jul 29. doi: 10.1038/s41375-026-03079.
    PubMed         Abstract available
    
    
18. MEYER AE, Heimbruch KE, Pulakanti K, Stelloh C, et al
    Cohesin haploinsufficiency and inv(16) cooperate to reinforce Fli1 gene transcriptional programs during acute myeloid leukemia initiation and maintenance.
    Leukemia. 2026 Jul 27. doi: 10.1038/s41375-026-03070.
    PubMed         Abstract available
    
    
19. KUBOTA Y, Okamoto Y, Imamura T, Kada A, et al
    Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia.
    Leukemia. 2026 Jul 27. doi: 10.1038/s41375-026-03077.
    PubMed        
    
    
20. COHEN R, Nemet S, Bezalel-Rosenberg S, Asher I, et al
    Low-normal immunoglobulin suggests monoclonal B-cell lymphocytosis and constitutional CLL susceptibility: a dual-mechanism analysis.
    Leukemia. 2026;40:1668-1675.
    PubMed         Abstract available
    
    
21. BICA V, Pacile AF, Boettcher M, Marano V, et al
    Organelle proteomics reveals novel metabolic vulnerabilities in FLT3-ITD cells.
    Leukemia. 2026;40:1657-1667.
    PubMed         Abstract available
    
    
22. WINTER L, Pawlowsky L, Muth A, Neumann AS, et al
    TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.
    Leukemia. 2026;40:1624-1635.
    PubMed         Abstract available
    
    

    
    PLoS One

23. AGHAJAN B, Ghaemi MR, Mosammam AM, Heshmati E, et al
    A systems biology approach to find representative genes in Acute Myeloid Leukemia.
    PLoS One. 2026;21:e0352167.
    PubMed         Abstract available
    
    
24. PLOENSIL P, Suwanwong Y, Phannasil P, Tarasuk M, et al
    Helminth-derived stefin-1 selectively reduces leukemic cell viability and promotes apoptosis in U937 cells.
    PLoS One. 2026;21:e0353364.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum